Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862962
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2021-04-23
Brief Title:
Study to Evaluate the Safety of the Fixed-dose Combination RosuvastatinEzetimibe for Patients With Dyslipidaemia
Sponsor:
Laboratorios Silanes SA de CV
Organization:
Laboratorios Silanes SA de CV
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-23
First Submit QC Date:
April 23 2021
Study First Post Date:
2021-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-28
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL